A-LiNK: Improving Outcomes in Autoimmune Liver Disease
Start Date
4/28/2022
Completion Date
6/30/2033
Summary
The Autoimmune Liver disease Network for Kids (A-LiNK) is a multi-institutional group with the mission to deliver the best care to kids with pediatric autoimmune liver disease (AILD). This study will establish a shared clinical registry and a learning health network for the participating sites focusing on collecting and transmitting clinical measurement data, information about processes, and participation in an improvement collaborative. Pediatric Autoimmune Hepatitis (AIH) and Primary Sclerosing Cholangitis (PSC), represent a spectrum of AILD which present unique diagnostic and therapeutic challenges.A lack of accepted guidelines for disease monitoring or symptom management results in wide treatment variation with liver transplants indicated in refractory, progressive disease. The aims of A-LiNK are to: 1.) Create a learning health network focused on patient-centered outcomes research characterized by transparent sharing among centers, common priorities, and feasible plans for implementing new practices; 2) shift from traditional investigator-driven study to a patient and family-centered approach, and 3.) improve clinical outcomes and quality of life for pediatric AILD patients.
Eligibility Criteria
Age Range: No minimum to No maximum
Interventions
No interventions
Conditions
Locations
Stanford University
Palo Alto, California 94304
United States
Riley Children's Health
Indianapolis, Indiana 46202
United States
St. Louis Children's Hospital
St Louis, Missouri 63110
United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229
United States
Nationwide Children's Hospital
Columbus, Ohio 43205
United States
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania 15224
United States
UT Southwestern Medical Center
Dallas, Texas 75390
United States
Seattle Children's Hospital
Seattle, Washington 98105
United States